Nialamide

Revision as of 16:47, 20 August 2015 by WikiBot (talk | contribs) (Protected "Nialamide": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
This image is provided by the National Library of Medicine.

WikiDoc Resources for Nialamide

Articles

Most recent articles on Nialamide

Most cited articles on Nialamide

Review articles on Nialamide

Articles on Nialamide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Nialamide

Images of Nialamide

Photos of Nialamide

Podcasts & MP3s on Nialamide

Videos on Nialamide

Evidence Based Medicine

Cochrane Collaboration on Nialamide

Bandolier on Nialamide

TRIP on Nialamide

Clinical Trials

Ongoing Trials on Nialamide at Clinical Trials.gov

Trial results on Nialamide

Clinical Trials on Nialamide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Nialamide

NICE Guidance on Nialamide

NHS PRODIGY Guidance

FDA on Nialamide

CDC on Nialamide

Books

Books on Nialamide

News

Nialamide in the news

Be alerted to news on Nialamide

News trends on Nialamide

Commentary

Blogs on Nialamide

Definitions

Definitions of Nialamide

Patient Resources / Community

Patient resources on Nialamide

Discussion groups on Nialamide

Patient Handouts on Nialamide

Directions to Hospitals Treating Nialamide

Risk calculators and risk factors for Nialamide

Healthcare Provider Resources

Symptoms of Nialamide

Causes & Risk Factors for Nialamide

Diagnostic studies for Nialamide

Treatment of Nialamide

Continuing Medical Education (CME)

CME Programs on Nialamide

International

Nialamide en Espanol

Nialamide en Francais

Business

Nialamide in the Marketplace

Patents on Nialamide

Experimental / Informatics

List of terms related to Nialamide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Nialamide (Niamid, Niamide, Nuredal, Surgex) is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant. It was withdrawn by Pfizer several decades ago due to the risk of hepatotoxicity.

References

Template:Antidepressants